3D Mammography Systems Market Size, Share and Global Trend By End User (Hospitals, Specialty Clinics, Diagnostic Centers, Others) and Regional Forecast, 2024-2032

The incidence of breast cancer is increasing in the developed and developing countries due to increasing urbanization and adoption of western lifestyles. Mammography enables the detection of breast cancer and other breast-related diseases. Mammography techniques are used for the screening and diagnosis of breast cancer among women. In 2011, the FDA approved the use of 3-dimensional (3-D) mammography or digital breast tomosynthesis which builds a 3-D image of the breast with multiple high-resolution x-rays, which is used in combination with a 2-D digital mammography image. According to the World Cancer Research Fund International, breast cancer is the second most common cancer globally, and there were over 2 million new cases registered for breast cancer in 2018.

Technological advancements in breast imaging technology and the rising incidence of breast cancer are some of the factors driving the growth of the global 3D mammography systems market. Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for the awareness, detection, and treatment of the breast cancer are some of the major factors expected to drive the growth of the global 3D mammography systems market.

However, radiation exposure risks and generation of false results are some of the factors are expected to impede the growth of the global 3D mammography systems market.

Key Players Covered

Some of the major companies that are present in the global 3D mammography systems market are Fujifilm Holdings Corporation, BMI Biomedical International s.r.l., Canon Inc., Carestream Health Inc., General Electric Company, Hologic, Inc., Metaltronica S.p.A., Planmed Oy, Siemens Healthineers, Villa Sistemi Medicali S.p.A., and others.

SEGMENTATION

Among end-user, hospitals and diagnostics centers are anticipated to grow at a significant CAGR due to the rising awareness among the patient population about breast cancer and faster detection systems.

Key Insights

• Reimbursement Scenario for Key Countries
• Incidence And Prevalence Of Breast Cancer 2018, Key Countries/ Region
• Recent Industry Developments Such as Partnerships, Mergers, and Acquisitions
• New Systems Launched, Key Players/ Region

Regional Analysis

North America accounted for the largest share of the global 3D mammography systems market in 2018. The rising incidence of breast cancer, high adoption of advanced diagnostic technologies and easy accessibility of the advanced mammography systems and increasing geriatric population in the region are some of the major factors driving the growth of the 3D mammography market. Asia Pacific region is expected to grow at a significant CAGR during the forecast period due to developing health care facilities and increasing awareness among patient and general population towards early screening of breast cancer.

Key Industry Developments

• In December 2017, Hologic Inc., received FDA approval for its new 3D mammography device that is superior to standard 2D mammography for routine breast cancer screening of women with dense breasts.
• In September 2014, General Electric Company received approval from the Food and Drug Administration for the sales of the 3-D breast-imaging technology in the U.S.